Medical and Pharmaceutical University of Oxford researchers explore AI breath analysis to transform COPD care COPD affects about three million people in the UK and is the country’s third biggest killer Joseph MortonSeptember 23, 2025
Medical and Pharmaceutical Breath Diagnostics leaders promote their mission at Miami investment conference The National Investment Banking Association's event unites micro and small cap companies with potential investors Rowan DunneSeptember 21, 2025
Medical and Pharmaceutical Samsung Medical Center develops deep learning model to predict lung cancer recurrence It divides patients who have undergone surgery into different risk categories Rowan DunneSeptember 17, 2025
Medical and Pharmaceutical University of Bath spinout tests real-time lung biopsy device A lung biopsy can confirm a diagnosis in the laboratory and reveal the molecular structure of a lesion Joseph MortonSeptember 17, 2025
Medical and Pharmaceutical Novocure’s electric fields device approved for treating lung cancer in Japan The gadget is also FDA-certified and has received a stamp of approval from EU regulators Rowan DunneSeptember 15, 2025
Medical and Pharmaceutical Lung cancer detection dominates as breath biopsy gains clinical traction Clinicians, researchers, and healthcare systems increasingly rely on breath biopsy to detect chronic diseases early Joseph MortonSeptember 12, 2025
Medical and Pharmaceutical AI-powered lung cancer detection debuts at Topeka’s St. Francis Hospital The program aims to prevent overlooked findings, surface patients who need additional review, and support long-term monitoring Joseph MortonSeptember 10, 2025
Medical and Pharmaceutical Breath Diagnostics adopts state-of-the-art mass spectrometer device for lung screening The Xevo TQ Absolute XR is one of the most sensitive and compact tandem quadrupole mass spectrometers available Rowan DunneSeptember 8, 2025
Crypto/Blockchain TNF Pharmaceuticals surges 16% on crypto pivot and LightSolver partnership The technology reduces energy costs by up to 90 per cent compared with conventional GPUs and high-performance computing systems Joseph MortonSeptember 8, 2025
Medical and Pharmaceutical Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug The approval marked a pivotal milestone for the company, transitioning it from a clinical-stage entity to a commercial-stage player Joseph MortonSeptember 5, 2025